Cathelicidin LL-37 in Health and Diseases of the Oral Cavity

被引:27
|
作者
Tokajuk, Joanna [1 ,2 ]
Deptula, Piotr [1 ]
Piktel, Ewelina [3 ]
Daniluk, Tamara [1 ]
Chmielewska, Sylwia [1 ]
Wollny, Tomasz [4 ]
Wolak, Przemyslaw [5 ]
Fiedoruk, Krzysztof [1 ]
Bucki, Robert [1 ]
机构
[1] Med Univ Bialystok, Dept Med Microbiol & Nanobiomed Engn, Mickiewicza 2C, PL-15222 Bialystok, Poland
[2] Dent & Med Tokajuk, Zelazna 9-7, PL-15297 Bialystok, Poland
[3] Med Univ Bialystok, Independent Lab Nanomed, Mickiewicza 2B, PL-15222 Bialystok, Poland
[4] Holy Cross Oncol Ctr Kielce, Artwinskiego 3, PL-25734 Kielce, Poland
[5] Jan Kochanowski Univ Kielce, Coll Med, Inst Med Sci, IX Wiekow Kielc 19A, PL-25317 Kielce, Poland
关键词
oarl cavity; human cathelicidin; antimicrobial peptides; immunomodulation; ANTIMICROBIAL PEPTIDE LL-37; GINGIVAL CREVICULAR FLUID; PORPHYROMONAS-GINGIVALIS; ANTIBACTERIAL ACTIVITY; GROWTH-FACTOR; SALIVARY CONCENTRATION; EPITHELIAL-CELLS; INNATE IMMUNITY; MYELOID CELLS; CANCER-CELLS;
D O I
10.3390/biomedicines10051086
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanisms for maintaining oral cavity homeostasis are subject to the constant influence of many environmental factors, including various chemicals and microorganisms. Most of them act directly on the oral mucosa, which is the mechanical and immune barrier of the oral cavity, and such interaction might lead to the development of various oral pathologies and systemic diseases. Two important players in maintaining oral health or developing oral pathology are the oral microbiota and various immune molecules that are involved in controlling its quantitative and qualitative composition. The LL-37 peptide is an important molecule that upon release from human cathelicidin (hCAP-18) can directly perform antimicrobial action after insertion into surface structures of microorganisms and immunomodulatory function as an agonist of different cell membrane receptors. Oral LL-37 expression is an important factor in oral homeostasis that maintains the physiological microbiota but is also involved in the development of oral dysbiosis, infectious diseases (including viral, bacterial, and fungal infections), autoimmune diseases, and oral carcinomas. This peptide has also been proposed as a marker of inflammation severity and treatment outcome.
引用
收藏
页数:30
相关论文
共 50 条
  • [31] The role of the microenvironment protein cathelicidin LL-37 in pancreatic ductal adenocarcinoma
    Sainz, Bruno, Jr.
    Frias, Javier
    Cloffi, Michele
    Alcala, Sonia
    Heeschen, Christopher
    CANCER RESEARCH, 2013, 73
  • [32] Pulmonary defense and the human cathelicidin hCAP-18/LL-37
    Fahy, RJ
    Wewers, MA
    IMMUNOLOGIC RESEARCH, 2005, 31 (02) : 75 - 89
  • [33] Cathelicidin LL-37: a defense molecule with a potential role in psoriasis pathogenesis
    Dombrowski, Yvonne
    Schauber, Juergen
    EXPERIMENTAL DERMATOLOGY, 2012, 21 (05) : 327 - 330
  • [34] The roles of cathelicidin LL-37 in immune defences and novel clinical applications
    Nijnik, Anastasia
    Hancock, Robert E. W.
    CURRENT OPINION IN HEMATOLOGY, 2009, 16 (01) : 41 - 47
  • [35] LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity
    Adam Fabisiak
    Natalia Murawska
    Jakub Fichna
    Pharmacological Reports, 2016, 68 : 802 - 808
  • [36] Cathelicidin peptide LL-37: A multifunctional peptide involved in heart disease
    Miao, Shuo
    Liu, Houde
    Yang, Qingyu
    Zhang, Yaping
    Chen, Tao
    Chen, Shuai
    Mao, Xin
    Zhang, Qingsong
    PHARMACOLOGICAL RESEARCH, 2024, 210
  • [37] The Human Cathelicidin LL-37, a Defensive Peptide Against Rotavirus Infection
    Zohreh Hosseini
    Mohammad Bagher Habibi Najafi
    Masoud Yavarmanesh
    Angila Ataei-Pirkooh
    International Journal of Peptide Research and Therapeutics, 2020, 26 : 911 - 919
  • [38] In silico assessment of missense point mutations on human cathelicidin LL-37
    Porto, William F.
    Alencar, Sergio A.
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2023, 118
  • [39] Expression of B-defensins, cathelicidin (LL-37) in skin tumors
    Whang, Kyu Uang
    Mo, Gang
    Lee, Jong Suk
    Lip, Young
    Lee, Jung Eun
    Hoon, Jung
    Park, Yoon Ji
    Il, Seung
    Kim, Ji Hoon
    Ki, Hong
    JOURNAL OF DERMATOLOGY, 2012, 39 : 34 - 34
  • [40] Serum levels of peptide cathelicidin LL-37 in elderly patients with depression
    Kozlowska, Elzbieta
    Wysokinski, Adam
    Brzezinska-Blaszczyk, Ewa
    PSYCHIATRY RESEARCH, 2017, 255 : 156 - 160